MRM Valuation

Medirom Healthcare Technologies Inc

Add to Watchlist

Advanced Chart

1.320

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

MRM Relative Valuation

MRM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MRM is overvalued; if below, it's undervalued.

Historical Valuation

Medirom Healthcare Technologies Inc (MRM) is now in the Fair zone, suggesting that its current forward PS ratio of 0.18 is considered Fairly compared with the five-year average of 0.00. The fair price of Medirom Healthcare Technologies Inc (MRM) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：1.32

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.71

P/B

Median3y

-6.94

Median5y

-4.11

-86.53

FCF Yield

Median3y

-41.26

Median5y

-30.94

Competitors Valuation Multiple

The average P/S ratio for MRM's competitors is 0.51, providing a benchmark for relative valuation. Medirom Healthcare Technologies Inc Corp (MRM) exhibits a P/S ratio of 0.18, which is -64.80% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

MRM.O

Medirom Healthcare Technologies Inc

0.18

Average P/S: 0.51

10.43M